— Know what they know.
Not Investment Advice

RVVQF OTC

RavenQuest BioMed Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +0.0% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $1236 mcap · 119M float · 0.046% daily turnover

Cash Flow Trends

Operating Cash Flow
-$11M -342.2% ▼
Capital Expenditures
$12M -1287710.4% ▼
5Y CAGR: +362.0%
Free Cash Flow
-$23M -830.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$3M -189.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2014FY2015FY2016FY2017FY2018
— Operating Activities —
Net Income-$61K-$76K-$81K-$3M-$30M
Depreciation & Amort.$0$0$0$286$2M
Stock-Based Comp.$0$0$0$46K$6M
Change in Working Capital$24K$56K$49K-$2M-$2M
Other Non-Cash Items$0$0$0$2M$14M
Operating Cash Flow-$37K-$20K-$32K-$3M-$11M
— Investing Activities —
Capital Expenditures$0$0$0-$952-$12M
Acquisitions (Net)$0$0$0-$158K-$16M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$34K$0$0$0$0
Investing Cash Flow$34K$0$0-$159K-$29M
— Financing Activities —
Net Debt Issuance$11K$12K$32K$0$14M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0-$267K$3M
Financing Cash Flow$11K$12K$32K$6M$37M
Net Change in Cash$8K-$8K-$922$3M-$3M
Cash End of Period$9K$2K$604$3M$363K
Free Cash Flow-$37K-$20K-$32K-$3M-$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms